These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1101 related articles for article (PubMed ID: 11929080)
1. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080 [TBL] [Abstract][Full Text] [Related]
2. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation. Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815 [TBL] [Abstract][Full Text] [Related]
3. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858 [TBL] [Abstract][Full Text] [Related]
4. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Rubello D; Mazzarotto R; Casara D Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117 [TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation. Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522 [TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [TBL] [Abstract][Full Text] [Related]
8. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin? Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617 [TBL] [Abstract][Full Text] [Related]
9. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy. Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
11. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
12. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
13. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
14. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Roelants V; Nayer PD; Bouckaert A; Beckers C Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756 [TBL] [Abstract][Full Text] [Related]
15. Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment. Pace L; Klain M; Albanese C; Salvatore B; Storto G; Soricelli A; Salvatore M Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):179-83. PubMed ID: 16205897 [TBL] [Abstract][Full Text] [Related]
16. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma. Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514 [TBL] [Abstract][Full Text] [Related]
18. Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence. Rosario PW; Furtado Mde S; Mineiro Filho AF; Lacerda RX; Calsolari MR Thyroid; 2012 Nov; 22(11):1165-9. PubMed ID: 23050784 [TBL] [Abstract][Full Text] [Related]
19. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420 [TBL] [Abstract][Full Text] [Related]
20. Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels. Pachón-Garrudo VM; Cuenca-Cuenca JI; Ruiz-Franco-Baux J; Borrego-Dorado I; Tirado-Hospital JL; Navarro-González E; Vázquez-Albertino R Rev Esp Med Nucl Imagen Mol; 2012; 31(6):315-21. PubMed ID: 23084014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]